 Blood sample will be obtained at baseline and every week before MV injection for the assessment of clinical hematology, biochemistry measurements and immunology index including immunoglobin, interleukin and interferon. Patients will be evaluated for toxicity throughout the study. Side effect, progression free survival, immunology index and general status will be recorded. 